BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9664517)

  • 1. The use of flow cytometry and RT-PCR in the detection of circulating PSA-positive cells in prostate cancer.
    Fadlon EJ; Hamdy FC
    Methods Mol Biol; 1998; 92():215-25. PubMed ID: 9664517
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
    Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
    Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA].
    de la Taille A; Muscatelli B; Colombel M; Jouault H; Amsellem S; Mazeman E; Abbou CC; Chopin D
    Prog Urol; 1998 Dec; 8(6):1058-64. PubMed ID: 9894270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
    Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F
    BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
    Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
    Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostate-specific membrane antigen. A new sensitive molecular indicator in metastasizing prostatic cancer].
    Kippersund JT; Haukeland B; Lilleeng BF; Daehlin L; Haukaas S; Høisaeter PA; Ogreid D
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3612-5. PubMed ID: 8539714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Berteau P; Dumas F; Loric S; Eschwège P; Gala JL
    J Urol; 1998 May; 159(5):1649-50. PubMed ID: 9554383
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between CD8+ T cells specific for prostate-specific antigen and level of disease in patients with prostate cancer.
    Elkord E; Rowbottom AW; Kynaston H; Williams PE
    Clin Immunol; 2006 Jul; 120(1):91-8. PubMed ID: 16458609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RT-PCR assay for detecting PSA mRNA in peripheral blood of prostate cancer patients].
    Okubo Y; Ito T
    Hinyokika Kiyo; 1999 Jan; 45(1):25-30. PubMed ID: 10086262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
    Shariat SF; Kattan MW; Song W; Bernard D; Gottenger E; Wheeler TM; Slawin KM
    Cancer Res; 2003 Sep; 63(18):5874-8. PubMed ID: 14522912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
    Llanes L; Ferruelo A; Luján M; Pascual C; García-Mediero JM; Berenguer A
    Prostate Cancer Prostatic Dis; 2005; 8(3):248-52. PubMed ID: 15897916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy.
    Tombal B; Van Cangh PJ; Loric S; Gala JL
    Prostate; 2003 Aug; 56(3):163-70. PubMed ID: 12772185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy.
    Hara N; Kasahara T; Kawasaki T; Bilim V; Tomita Y; Obara K; Takahashi K
    Br J Cancer; 2001 Aug; 85(4):557-62. PubMed ID: 11506496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of PSA mRNA in prostate cancer patients' blood].
    Ito T; Okubo Y; Tachibana M
    Rinsho Byori; 2001 Oct; 49(10):974-7. PubMed ID: 11769474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of circulating epithelial cells in prostate cancer].
    de la Taille A; Colombel M; Muscatelli B; Abbou CC; Jouault H; Amsallem S; Chopin D
    Chirurgie; 1997; 122(4):268-73. PubMed ID: 9501553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating PSA-containing macrophages as a possible target for the detection of prostate cancer: a three-color/five-parameter flow cytometric study on peripheral blood samples.
    Leers MP; Nap M; Herwig R; Delaere K; Nauwelaers F
    Am J Clin Pathol; 2008 Apr; 129(4):649-56. PubMed ID: 18343793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
    Ghossein RA; Carusone L; Bhattacharya S
    In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
    Albers P; Ko Y; Wardelmann E; Schmidt D; Adam M; Vetter H; Müller SC
    Anticancer Res; 2000; 20(3B):2107-11. PubMed ID: 10928161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
    Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
    J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
    Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
    Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.